Amelioration of experimental autoimmune encephalomyelitis by the quinoline-3-carboxamide paquinimod: Reduced priming of proinflammatory effector CD4+ T cells

American Journal of Pathology

Volumn 182, Issue 5, 2013, Pages 1671-1680

  Helmersson, Sofia ^a   Sundstedt, Anette ^b   Deronic, Adnan ^a   Leanderson, Tomas ^a   Ivars, Fredrik ^a  

^a LUND UNIVERSITY   (Sweden)

^b Active Biotech Research AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; PAQUINIMOD;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BRAIN; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; ENCEPHALOMYELITIS; LYMPH NODE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T CELL DEPLETION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD11B; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CROSS-PRIMING; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNOLOGIC MEMORY; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-17; MICE; MICE, INBRED C57BL; QUINOLINES; SPLEEN;

EID: 84876572127     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.01.032     Document Type: Article

References (48)

1. G. Comi, O. Abramsky, T. Arbizu, A. Boyko, R. Gold, E. Havrdová, S. Komoly, K. Selmaj, B. Sharrack, M. Filippi LAQ/5063 Study Group Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study Mult Scler 16 2010 1360 1366
2. G. Comi, A. Pulizzi, M. Rovaris, O. Abramsky, T. Arbizu, A. Boiko, R. Gold, E. Havrdova, S. Komoly, K. Selmaj, B. Sharrack, M. Filippi LAQ/5062 Study Group Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study Lancet 371 2008 2085 2092
3. C. Polman, F. Barkhof, M. Sandberg-Wollheim, A. Linde, O. Nordle, T. Nederman Laquinimod in Relapsing MS Study Group Treatment with laquinimod reduces development of active MRI lesions in relapsing MS Neurology 64 2005 987 991
4. O. Bratt, M. Häggman, G. Ahlgren, O. Nordle, A. Björk, and J.E. Damber Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer Br J Cancer 101 2009 1233 1240
5. A.A. Bengtsson, G. Sturfelt, C. Lood, L. Rönnblom, R.F. van Vollenhoven, B. Axelsson, B. Sparre, H. Tuvesson, M.W. Ohman, and T. Leanderson Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging study in patients with systemic lupus erythematosus Arthritis Rheum 64 2012 1579 1588
6. J. Björk, and S. Kleinau Paradoxical effects of LS-2616 (linomide) treatment 'type II collagen arthritis model in mice Agents Actions 27 1989 319 321
7. C. Brunmark, A. Runström, L. Ohlsson, B. Sparre, T. Brodin, M. Aström, and G. Hedlund The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis J Neuroimmunol 130 2002 163 172
8. D.J. Gross, L. Weiss, I. Reibstein, G. Hedlund, E. Dahlén, M.J. Rapoport, and S. Slavin The immunomodulator linomide: role in treatment and prevention of autoimmune diabetes mellitus Int Immunopharmacol 1 2001 1131 1139
9. A. Runström, T. Leanderson, L. Ohlsson, and B. Axelsson Inhibition of the development of chronic experimental autoimmune encephalomyelitis by laquinimod (ABR-215062) in IFN-beta k.o. and wild type mice J Neuroimmunol 173 2006 69 78
10. C. Wegner, C. Stadelmann, R. Pförtner, E. Raymond, S. Feigelson, R. Alon, B. Timan, L. Hayardeny, and W. Brück Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis J Neuroimmunol 227 2010 133 143
11. J.S. Yang, L.Y. Xu, B.G. Xiao, G. Hedlund, and H. Link Laquinimod (ABR-215062) suppresses the development of experimental autoimmune encephalomyelitis, modulates the Th1/Th2 balance and induces the Th3 cytokine TGF-beta in Lewis rats J Neuroimmunol 156 2004 3 9
12. P. Björk, A. Björk, T. Vogl, M. Stenström, D. Liberg, A. Olsson, J. Roth, F. Ivars, and T. Leanderson Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides PLoS Biol 7 2009 e97
13. M. Riva, E. Källberg, P. Björk, D. Hancz, T. Vogl, J. Roth, F. Ivars, and T. Leanderson Induction of nuclear factor-kappaB responses by the S100A9 protein is Toll-like receptor-4-dependent Immunology 137 2012 172 182
14. M.A. Kroenke, T.J. Carlson, A.V. Andjelkovic, and B.M. Segal IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition J Exp Med 205 2008 1535 1541
15. J.R. Lees, P.T. Golumbek, J. Sim, D. Dorsey, and J.H. Russell Regional CNS responses to IFN-gamma determine lesion localization patterns during EAE pathogenesis J Exp Med 205 2008 2633 2642
16. D. Luger, P.B. Silver, J. Tang, D. Cua, Z. Chen, Y. Iwakura, E.P. Bowman, N.M. Sgambellone, C.C. Chan, and R.R. Caspi Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category J Exp Med 205 2008 799 810
17. I.M. Stromnes, L.M. Cerretti, D. Liggitt, R.A. Harris, and J.M. Goverman Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells Nat Med 14 2008 337 342
18. S.M. Kerfoot, E.M. Long, M.J. Hickey, G. Andonegui, B.M. Lapointe, R.C. Zanardo, C. Bonder, W.G. James, S.M. Robbins, and P. Kubes TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease J Immunol 173 2004 7070 7077
19. X. Chen, O.M. Howard, and J.J. Oppenheim Pertussis toxin by inducing IL-6 promotes the generation of IL-17-producing CD4 cells J Immunol 178 2007 6123 6129
20. D.S. Linthicum, J.J. Munoz, and A. Blaskett Acute experimental autoimmune encephalomyelitis in mice. I. Adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the central nervous system Cell Immunol 73 1982 299 310
21. U. Schulze-Topphoff, A. Shetty, M. Varrin-Doyer, N. Molnarfi, S.A. Sagan, R.A. Sobel, P.A. Nelson, and S.S. Zamvil Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity PLoS One 7 2012 e33797
22. J. Thöne, G. Ellrichmann, S. Seubert, I. Peruga, D.H. Lee, R. Conrad, L. Hayardeny, G. Comi, S. Wiese, R.A. Linker, and R. Gold Modulation of autoimmune demyelination by laquinimod via induction of brain-derived neurotrophic factor Am J Pathol 180 2012 267 274
23. L.P. Zou, N. Abbas, I. Volkmann, I. Nennesmo, M. Levi, B. Wahren, B. Winblad, G. Hedlund, and J. Zhu Suppression of experimental autoimmune neuritis by ABR-215062 is associated with altered Th1/Th2 balance and inhibited migration of inflammatory cells into the peripheral nerve tissue Neuropharmacology 42 2002 731 739
24. M. Gurevich, T. Gritzman, R. Orbach, T. Tuller, A. Feldman, and A. Achiron Laquinimod suppress antigen presentation in relapsing-remitting multiple sclerosis: in-vitro high-throughput gene expression study J Neuroimmunol 221 2010 87 94
25. M.K. Mishra, J. Wang, C. Silva, M. Mack, and V.W. Yong Kinetics of proinflammatory monocytes in a model of multiple sclerosis and its perturbation by laquinimod Am J Pathol 181 2012 642 651
26. R.N. Dogan, A. Elhofy, and W.J. Karpus Production of CCL2 by central nervous system cells regulates development of murine experimental autoimmune encephalomyelitis through the recruitment of TNF- and iNOS-expressing macrophages and myeloid dendritic cells J Immunol 180 2008 7376 7384
27. I.L. King, T.L. Dickendesher, and B.M. Segal Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease Blood 113 2009 3190 3197
28. A. Mildner, M. Mack, H. Schmidt, W. Brück, M. Djukic, M.D. Zabel, A. Hille, J. Priller, and M. Prinz CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system Brain 132 2009 2487 2500
29. B. Zhu, J.K. Kennedy, Y. Wang, C. Sandoval-Garcia, L. Cao, S. Xiao, C. Wu, W. Elyaman, and S.J. Khoury Plasticity of Ly-6C(hi) myeloid cells in T cell regulation J Immunol 187 2011 2418 2432
30. C. Auffray, D.K. Fogg, E. Narni-Mancinelli, B. Senechal, C. Trouillet, N. Saederup, J. Leemput, K. Bigot, L. Campisi, M. Abitbol, T. Molina, I. Charo, D.A. Hume, A. Cumano, G. Lauvau, and F. Geissmann CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation J Exp Med 206 2009 595 606
31. C. Cheong, I. Matos, J.H. Choi, D.B. Dandamudi, E. Shrestha, M.P. Longhi, K.L. Jeffrey, R.M. Anthony, C. Kluger, G. Nchinda, H. Koh, A. Rodriguez, J. Idoyaga, M. Pack, K. Velinzon, C.G. Park, and R.M. Steinman Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas Cell 143 2010 416 429
32. A. Flores-Langarica, J.L. Marshall, S. Bobat, E. Mohr, J. Hitchcock, E.A. Ross, R.E. Coughlan, M. Khan, N. Van Rooijen, I.R. Henderson, I.C. Maclennan, and A.F. Cunningham T-zone localized monocyte-derived dendritic cells promote Th1 priming to Salmonella [Erratum appeared in Eur J Immunol 2011, 41:3085] Eur J Immunol 41 2011 2654 2665
33. B. León, M. López-Bravo, and C. Ardavín Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania Immunity 26 2007 519 531
34. H. Nakano, K.L. Lin, M. Yanagita, C. Charbonneau, D.N. Cook, T. Kakiuchi, and M.D. Gunn Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses Nat Immunol 10 2009 394 402
35. N.V. Serbina, T.P. Salazar-Mather, C.A. Biron, W.A. Kuziel, and E.G. Pamer TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection Immunity 19 2003 59 70
36. I.L. King, M.A. Kroenke, and B.M. Segal GM-CSF-dependent, CD103+ dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunization J Exp Med 207 2010 953 961
37. B.T. Edelson, T.R. Bradstreet, K.C. Wumesh, K. Hildner, J.W. Herzog, J. Sim, J.H. Russell, T.L. Murphy, E.R. Unanue, and K.M. Murphy Batf3-dependent CD11b(low/-) peripheral dendritic cells are GM-CSF-independent and are not required for Th cell priming after subcutaneous immunization PLoS One 6 2011 e25660
38. M. Stenström, P. Anderson, L. Eroukhmanoff, T. Leanderson, and F. Ivars Selective depletion of splenic CD4 dendritic cells in mice treated with immunomodulatory quinoline-3-carboxamide ABR-215757 Int Immunopharmacol 10 2010 837 842
39. S. Helmersson, M. Stenström, T. Leanderson, and F. Ivars Specific effect of immunomodulatory quinoline-3-carboxamide ABR-215757 in GM-CSF stimulated bone marrow cell cultures: block of initiation of proliferation of Gr-1+ cells Int Immunopharmacol 11 2011 1045 1051
40. A. Billiau, and P. Matthys Modes of action of Freund's adjuvants in experimental models of autoimmune diseases J Leukoc Biol 70 2001 849 860
41. T.J. Fleming, M.L. Fleming, and T.R. Malek Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family J Immunol 151 1993 2399 2408
42. J.M. Daley, A.A. Thomay, M.D. Connolly, J.S. Reichner, and J.E. Albina Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice J Leukoc Biol 83 2008 64 70
43. B. Ajami, J.L. Bennett, C. Krieger, K.M. McNagny, and F.M. Rossi Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool Nat Neurosci 14 2011 1142 1149
44. C. Auffray, M.H. Sieweke, and F. Geissmann Blood monocytes: development, heterogeneity, and relationship with dendritic cells Annu Rev Immunol 27 2009 669 692
45. J. Banchereau, and R.M. Steinman Dendritic cells and the control of immunity Nature 392 1998 245 252
46. E.J. Allenspach, M.P. Lemos, P.M. Porrett, L.A. Turka, and T.M. Laufer Migratory and lymphoid-resident dendritic cells cooperate to efficiently prime naive CD4 T cells Immunity 29 2008 795 806
47. A.A. Itano, S.J. McSorley, R.L. Reinhardt, B.D. Ehst, E. Ingulli, A.Y. Rudensky, and M.K. Jenkins Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity Immunity 19 2003 47 57
48. D.A. Drevets, J.E. Schawang, V.K. Mandava, M.J. Dillon, and P.J. Leenen Severe Listeria monocytogenes infection induces development of monocytes with distinct phenotypic and functional features J Immunol 185 2010 2432 2441